FDA Cleared New Three-in-One Respiratory Test
The new diagnostic identifies COVID, flu, and RSV using a single swab, providing clarity when symptoms overlap.
Updated on Sept. 22, 2026 in Diseases — General
Live Poll
Do you feel having home diagnostic tests for multiple viruses makes you better prepared for illness?
The FDA has cleared a new diagnostic test that detects COVID-19, influenza, and RSV from one swab. The tool helps individuals distinguish between these common respiratory illnesses, which often present with similar symptoms.
Why it matters
Distinguishing between these viruses is difficult because their symptoms frequently overlap, but identifying the correct pathogen can guide the appropriate approach to care and recovery.
In a study of 1,263 symptomatic individuals conducted across 10 U.S. cities, the test demonstrated a 92% to 94% sensitivity for identifying viral infections. This performance exceeds that of older rapid flu tests, which typically range from 51% to 67.5% in sensitivity.
The players
Food and Drug Administration
The federal agency responsible for protecting public health by ensuring the safety and effectiveness of medical devices and diagnostics.
The details
The device uses a single swab to screen for four viral pathogens simultaneously. By isolating the genetic markers of each virus, the test provides a more comprehensive picture of the infection than previous rapid options, which historically struggled with low sensitivity, such as the 17.8% detection rate seen during the 2009 H1N1 pandemic.
Timeline
2009: Evaluation of rapid test sensitivity during the H1N1 pandemic.
2018: General review of rapid influenza test sensitivity.
October 2024 to April 2025: Duration of the FDA clearance study.
Health Landscape
This clearance marks a significant technical departure from the reliability benchmarks established during the 2009 H1N1 pandemic. It represents a shift toward more accurate, multi-pathogen screening tools that address the long-standing challenge of low sensitivity in point-of-care testing.
When respiratory symptoms arise, ask your primary care provider if a multi-pathogen test is appropriate for your situation. Discussing the limitations and accuracy of available tests can help you make informed decisions about your health and care.
The takeaway
Advancements in multi-pathogen diagnostics offer a clearer path to identifying respiratory infections when symptoms overlap. If you are experiencing symptoms, prioritize a conversation with your physician to determine the most effective diagnostic strategy for your specific health needs.
Further reading
Learn more about the latest innovations in home diagnostics in our section on Diseases — General.
Source note: This article includes information reported by Quartz.
Live Poll
Do you feel having home diagnostic tests for multiple viruses makes you better prepared for illness?
